From: Mortality risk factors among hospitalized children with severe pertussis
Characteristics | Total | Survivors | Deaths | P-value |
---|---|---|---|---|
N = 144 | N = 131 | N = 13 | ||
Number | Number | Number | ||
Macrolide treatments | ||||
No use | 4 | 3 | 1 | 0.001 |
< 7 days after the onset of symptoms | 15 | 10 | 5 | |
7–14 days after the onset of symptoms | 64 | 58 | 6 | |
> 14 days after the onset of symptoms | 61 | 60 | 1 | |
Azithromycin | 118 | 108 | 10 | 0.704 |
Erythromycin | 28 | 24 | 4 | 0.281 |
Corticosteroid therapy | 24 | 17 | 7 | 0.001 |
Immunoglobulin therapy | 35 | 31 | 4 | 0.518 |
Respiratory support treatments | ||||
Oxygen | 32 | 32 | 0 | 0.038 |
Non-invasive ventilation | 6 | 5 | 1 | 0.439 |
Need for conventional mechanical ventilation | 18 | 9 | 9 | < 0.001 |
Need for high-frequency ventilation | 11 | 8 | 3 | 0.062 |
The length of Mechanical ventilation > 7 days | 15 | 13 | 2 | 0.627 |
Life support treatments | ||||
Exchange blood transfusion | 11 | 8 | 3 | 0.062 |
CRRT | 6 | 3 | 3 | 0.010 |
Inhalation of NO | 4 | 0 | 4 | < 0.001 |
ECMO | 2 | 1 | 1 | 0.173 |